TRUMAB 440MG

Price 5300 INR/ Vial

Get a Price/Quote

MOQ : 5 Vials

TRUMAB 440MG Specification

Pacakaging (Quantity Per Box)
1 x 440 mg Vial + 1 x 20 ml Sterile Water for Injection

Salt Composition
Trastuzumab

Indication
Early breast cancer, metastatic breast cancer, metastatic gastric cancer (HER2-positive)

Dosage Form
Intravenous infusion

Origin of Medicine
Biological

Drug Type
Biological/Anticancer

Ingredients
Trastuzumab lyophilized powder for concentrate for solution for infusion.

Physical Form
Lyophilized powder

Function
Monoclonal antibody targeted therapy

Recommended For
HER2-positive breast cancer, HER2-positive metastatic gastric cancer

Dosage
As directed by physician; usual initial dose 8 mg/kg intravenous infusion, followed by 6 mg/kg every 3 weeks

Dosage Guidelines
Administer under the supervision of a qualified physician experienced in anticancer therapy

Suitable For
Adults

Quantity
1 vial

Storage Instructions
Store at 2C to 8C. Do not freeze.

Strength
440 mg/vial

Reconstitution Required
Yes (with sterile water for injection before use)

ATC Code
L01XC03

Administration Route
Intravenous

Therapeutic Class
Antineoplastic agents

Shelf Life
24 months from the date of manufacturing

Brand Name
TRUMAB

Marketed In
India

Container Type
Glass vial

Warning
Not to be used during pregnancy and lactation unless absolutely necessary. Caution in cardiac patients.

Prescription Required
Yes

Product Registration
Registered under Indian FDA and other regulatory bodies

About TRUMAB 440MG

Trazumab 440mg Solution for Infusion is used in the treatment of breast and stomach cancer. It works by killing the cancer cells by inhibiting HER2 (human epidermal growth factor receptor protein).Trazumab 440mg Solution for Infusion is given as an injection by a qualified medical professional. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.The most common side effects of this medicine include nausea, headache, rash, insomnia, and infection. This medicine may reduce the number of blood cells (decrease red blood and white blood cells) in your blood, thereby, increasing the susceptibility to infections. Regular blood tests are required to check your blood cells along with heart, liver, and blood uric acid levels. You must have to inform your doctor if you experience breathlessness, cough, shivering, swelling of legs and arm.Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy

Targeted Therapy for HER2-Positive Cancers

TRUMAB 440MG is designed as a precision therapy for patients diagnosed with HER2-positive breast and metastatic gastric cancers. By specifically targeting cancer cells expressing the HER2 protein, this monoclonal antibody delivers a focused treatment approach while sparing most healthy cells. Its effectiveness stems from blocking HER2 signaling pathways, contributing to better disease management and outcomes.

Professional Administration and Dosage Guidance

Administration of TRUMAB 440MG requires careful preparation and professional oversight. The medication must first be reconstituted with 20 ml sterile water for injection and then infused intravenously in doses prescribed by a qualified physician. Initial dosing is typically 8 mg/kg, followed by 6 mg/kg every three weeks, individualized according to the patient's health status and response.

Safe Storage and Usage Precautions

TRUMAB should be stored at a temperature between 2C and 8C and protected from freezing to maintain its stability. Due to its potent biological action, use during pregnancy or lactation is discouraged unless absolutely necessary. Vigilance is advised in patients with cardiac conditions, and all infusions should take place under experienced medical supervision.

FAQ's of TRUMAB 440MG:

Q: How should TRUMAB 440MG be administered?

A: TRUMAB 440MG is administered as an intravenous infusion after reconstitution with sterile water for injection. The dosing and infusion should only be performed by a healthcare professional experienced in anticancer therapies.

Q: What conditions is TRUMAB 440MG recommended for?

A: This medication is recommended for adults diagnosed with HER2-positive early breast cancer, metastatic breast cancer, and HER2-positive metastatic gastric cancer.

Q: When should I not use TRUMAB 440MG?

A: TRUMAB should not be used during pregnancy or lactation unless the potential benefit outweighs the risk, and should be used with caution in patients with cardiac disease.

Q: Where should I store TRUMAB 440MG?

A: The vial should be stored in a refrigerator at temperatures between 2C and 8C. Do not freeze the medication, and keep it out of reach of children.

Q: What is the usual dosage regimen for TRUMAB 440MG?

A: The typical initial dose is 8 mg per kg body weight by intravenous infusion, followed by 6 mg/kg every three weeks, but individual dosing will be determined by a physician.

Q: What is the process for preparing TRUMAB 440MG for use?

A: Before administration, the lyophilized powder must be reconstituted with 20 ml of sterile water for injection provided in the packaging, followed by preparation for intravenous infusion by trained medical staff.

Q: What are the benefits of using TRUMAB 440MG?

A: TRUMAB provides targeted action against HER2-positive cancer cells, leading to improved cancer management, better disease control, and potentially favorable patient outcomes with a reduced impact on healthy tissue.

Tell us about your requirement